939 related articles for article (PubMed ID: 32798473)
21. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study.
Petrilli CM; Jones SA; Yang J; Rajagopalan H; O'Donnell L; Chernyak Y; Tobin KA; Cerfolio RJ; Francois F; Horwitz LI
BMJ; 2020 May; 369():m1966. PubMed ID: 32444366
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for adverse clinical outcomes with COVID-19 in China: a multicenter, retrospective, observational study.
Xu PP; Tian RH; Luo S; Zu ZY; Fan B; Wang XM; Xu K; Wang JT; Zhu J; Shi JC; Chen F; Wan B; Yan ZH; Wang RP; Chen W; Fan WH; Zhang C; Lu MJ; Sun ZY; Zhou CS; Zhang LN; Xia F; Qi L; Zhang W; Zhong J; Liu XX; Zhang QR; Lu GM; Zhang LJ
Theranostics; 2020; 10(14):6372-6383. PubMed ID: 32483458
[No Abstract] [Full Text] [Related]
23. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.
Wang Y; Zhang D; Du G; Du R; Zhao J; Jin Y; Fu S; Gao L; Cheng Z; Lu Q; Hu Y; Luo G; Wang K; Lu Y; Li H; Wang S; Ruan S; Yang C; Mei C; Wang Y; Ding D; Wu F; Tang X; Ye X; Ye Y; Liu B; Yang J; Yin W; Wang A; Fan G; Zhou F; Liu Z; Gu X; Xu J; Shang L; Zhang Y; Cao L; Guo T; Wan Y; Qin H; Jiang Y; Jaki T; Hayden FG; Horby PW; Cao B; Wang C
Lancet; 2020 May; 395(10236):1569-1578. PubMed ID: 32423584
[TBL] [Abstract][Full Text] [Related]
24. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
[TBL] [Abstract][Full Text] [Related]
25. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study.
Götzinger F; Santiago-García B; Noguera-Julián A; Lanaspa M; Lancella L; Calò Carducci FI; Gabrovska N; Velizarova S; Prunk P; Osterman V; Krivec U; Lo Vecchio A; Shingadia D; Soriano-Arandes A; Melendo S; Lanari M; Pierantoni L; Wagner N; L'Huillier AG; Heininger U; Ritz N; Bandi S; Krajcar N; Roglić S; Santos M; Christiaens C; Creuven M; Buonsenso D; Welch SB; Bogyi M; Brinkmann F; Tebruegge M;
Lancet Child Adolesc Health; 2020 Sep; 4(9):653-661. PubMed ID: 32593339
[TBL] [Abstract][Full Text] [Related]
26. Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy.
Vena A; Giacobbe DR; Di Biagio A; Mikulska M; Taramasso L; De Maria A; Ball L; Brunetti I; Loconte M; Patroniti NA; Robba C; Delfino E; Dentone C; Magnasco L; Nicolini L; Toscanini F; Bavastro M; Cerchiaro M; Barisione E; Giacomini M; Mora S; Baldi F; Balletto E; Berruti M; Briano F; Sepulcri C; Dettori S; Labate L; Mirabella M; Portunato F; Pincino R; Russo C; Tutino S; Pelosi P; Bassetti M;
Clin Microbiol Infect; 2020 Nov; 26(11):1537-1544. PubMed ID: 32810610
[TBL] [Abstract][Full Text] [Related]
27. Cancer inpatients with COVID-19: A report from the Brazilian National Cancer Institute.
de Melo AC; Thuler LCS; da Silva JL; de Albuquerque LZ; Pecego AC; Rodrigues LOR; da Conceição MS; Garrido MM; Quintella Mendes GL; Mendes Pereira ACP; Soares MA; Viola JPB;
PLoS One; 2020; 15(10):e0241261. PubMed ID: 33104715
[TBL] [Abstract][Full Text] [Related]
28. Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial.
Sivapalan P; Ulrik CS; Bojesen RD; Lapperre TS; Eklöf JV; Håkansson KEJ; Browatzki A; Tidemansen C; Wilcke JT; Janner J; Gottlieb V; Meteran H; Porsbjerg C; Madsen BL; Moberg M; Pedersen L; Benfield TL; Lundgren JD; Knop FK; Biering-Sørensen T; Ghanizada M; Sonne TP; Bødtger UCS; Jensen SG; Rasmussen DB; Brøndum E; Tupper OD; Sørensen SW; Alstrup G; Laursen CB; Møller UW; Sverrild A; Jensen JS
Trials; 2020 Jun; 21(1):513. PubMed ID: 32522282
[TBL] [Abstract][Full Text] [Related]
29. Cancer history is an independent risk factor for mortality in hospitalized COVID-19 patients: a propensity score-matched analysis.
Meng Y; Lu W; Guo E; Liu J; Yang B; Wu P; Lin S; Peng T; Fu Y; Li F; Wang Z; Li Y; Xiao R; Liu C; Huang Y; Lu F; Wu X; You L; Ma D; Sun C; Wu P; Chen G
J Hematol Oncol; 2020 Jun; 13(1):75. PubMed ID: 32522278
[TBL] [Abstract][Full Text] [Related]
30. 30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: A prospective cohort study.
Giacomelli A; Ridolfo AL; Milazzo L; Oreni L; Bernacchia D; Siano M; Bonazzetti C; Covizzi A; Schiuma M; Passerini M; Piscaglia M; Coen M; Gubertini G; Rizzardini G; Cogliati C; Brambilla AM; Colombo R; Castelli A; Rech R; Riva A; Torre A; Meroni L; Rusconi S; Antinori S; Galli M
Pharmacol Res; 2020 Aug; 158():104931. PubMed ID: 32446978
[TBL] [Abstract][Full Text] [Related]
31. Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial.
Garcia-Vicuña R; Abad-Santos F; González-Alvaro I; Ramos-Lima F; Sanz JS
Trials; 2020 Sep; 21(1):772. PubMed ID: 32907638
[TBL] [Abstract][Full Text] [Related]
32. Survival study of hospitalised patients with concurrent COVID-19 and haematological malignancies.
Martín-Moro F; Marquet J; Piris M; Michael BM; Sáez AJ; Corona M; Jiménez C; Astibia B; García I; Rodríguez E; García-Hoz C; Fortún-Abete J; Herrera P; López-Jiménez J
Br J Haematol; 2020 Jul; 190(1):e16-e20. PubMed ID: 32379921
[No Abstract] [Full Text] [Related]
33. Characteristics, Treatment Outcomes and Role of Hydroxychloroquine among 522 COVID-19 hospitalized patients in Jaipur City: An Epidemio-Clinical Study.
Bhandari S; Singh A; Sharma R; Rankawat G; Banerjee S; Gupta V; Dube A; Kakkar S; Sharma S; Keswani P; Agrawal A; Tak A; Nawal CL
J Assoc Physicians India; 2020 Jun; 68(6):13-19. PubMed ID: 32610873
[TBL] [Abstract][Full Text] [Related]
34. Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study.
Pinato DJ; Tabernero J; Bower M; Scotti L; Patel M; Colomba E; Dolly S; Loizidou A; Chester J; Mukherjee U; Zambelli A; Dalla Pria A; Aguilar-Company J; Ottaviani D; Chowdhury A; Merry E; Salazar R; Bertuzzi A; Brunet J; Lambertini M; Tagliamento M; Pous A; Sita-Lumsden A; Srikandarajah K; Colomba J; Pommeret F; Seguí E; Generali D; Grisanti S; Pedrazzoli P; Rizzo G; Libertini M; Moss C; Evans JS; Russell B; Harbeck N; Vincenzi B; Biello F; Bertulli R; Liñan R; Rossi S; Carmona-García MC; Tondini C; Fox L; Baggi A; Fotia V; Parisi A; Porzio G; Saponara M; Cruz CA; García-Illescas D; Felip E; Roqué Lloveras A; Sharkey R; Roldán E; Reyes R; Earnshaw I; Ferrante D; Marco-Hernández J; Ruiz-Camps I; Gaidano G; Patriarca A; Bruna R; Sureda A; Martinez-Vila C; Sanchez de Torre A; Cantini L; Filetti M; Rimassa L; Chiudinelli L; Franchi M; Krengli M; Santoro A; Prat A; Van Hemelrijck M; Diamantis N; Newsom-Davis T; Gennari A; Cortellini A;
Lancet Oncol; 2021 Dec; 22(12):1669-1680. PubMed ID: 34741822
[TBL] [Abstract][Full Text] [Related]
35. Association of Race and Ethnicity With Comorbidities and Survival Among Patients With COVID-19 at an Urban Medical Center in New York.
Kabarriti R; Brodin NP; Maron MI; Guha C; Kalnicki S; Garg MK; Racine AD
JAMA Netw Open; 2020 Sep; 3(9):e2019795. PubMed ID: 32975574
[TBL] [Abstract][Full Text] [Related]
36. How important is obesity as a risk factor for respiratory failure, intensive care admission and death in hospitalised COVID-19 patients? Results from a single Italian centre.
Rottoli M; Bernante P; Belvedere A; Balsamo F; Garelli S; Giannella M; Cascavilla A; Tedeschi S; Ianniruberto S; Rosselli Del Turco E; Tonetti T; Ranieri VM; Poggioli G; Manzoli L; Pagotto U; Viale P; Bartoletti M
Eur J Endocrinol; 2020 Oct; 183(4):389-397. PubMed ID: 32674071
[TBL] [Abstract][Full Text] [Related]
37. Factors associated with the duration of hospitalisation among COVID-19 patients in Vietnam: A survival analysis.
Thai PQ; Toan DTT; Son DT; Van HTH; Minh LN; Hung LX; Toan NV; Hoat LN; Luong DH; Khue LN; Khoa NT; Huong LT
Epidemiol Infect; 2020 Jun; 148():e114. PubMed ID: 32517822
[TBL] [Abstract][Full Text] [Related]
38. High mortality among hospital-acquired COVID-19 infection in patients with cancer: A multicentre observational cohort study.
Elkrief A; Desilets A; Papneja N; Cvetkovic L; Groleau C; Lakehal YA; Shbat L; Richard C; Malo J; Belkaid W; Cook E; Doucet S; Tran TH; Jao K; Daaboul N; Bhang E; Loree JM; Miller WH; Vinh DC; Bouganim N; Batist G; Letendre C; Routy B
Eur J Cancer; 2020 Nov; 139():181-187. PubMed ID: 33035991
[TBL] [Abstract][Full Text] [Related]
39. The burden of hepatitis E among patients with haematological malignancies: A retrospective European cohort study.
von Felden J; Alric L; Pischke S; Aitken C; Schlabe S; Spengler U; Giordani MT; Schnitzler P; Bettinger D; Thimme R; Xhaard A; Binder M; Ayuk F; Lohse AW; Cornelissen JJ; de Man RA; Mallet V
J Hepatol; 2019 Sep; 71(3):465-472. PubMed ID: 31108159
[TBL] [Abstract][Full Text] [Related]
40. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
